Preprocedural characteristics and echocardiography between none/mild and moderate/severe TR grade
| None/mild TR, n=36 | Moderate/severe TR, n=44 | P value | |
| Age, mean±SD (years) | 70±8.3 | 73±8.8 | 0.08 |
| Male gender | 25 | 35 | 0.31 |
| PAD | 3 | 6 | 0.50 |
| Chronic renal disease | 15 | 18 | 1 |
| Diabetes mellitus | 16 | 18 | 0.82 |
| Dilated cardiomyopathy | 18 | 23 | 1 |
| Ischaemic cardiomyopathy | 18 | 21 | 1 |
| NYHA functional class, mean±SD | 3.3±0.45 | 3.2±0.48 | 0.63 |
| Previous CRT | 16 | 17 | 0.65 |
| Previous ICD | 18 | 24 | 0.82 |
| Logistic EuroSCORE, mean±SD | 32±21 | 36±19 | 0.45 |
| Echocardiography | |||
| LVEF, mean±SD (%) | 23±5.1 | 22±5.5 | 0.56 |
| MR grade, mean±SD | 2.9±0.33 | 3.0±0.37 | 0.21 |
| TR grade, mean±SD | 0.92±0.28 | 2.2±0.42 | <0.001 |
| LVDd, mean±SD (mm) | 73±7.2 | 73±5.7 | 0.98 |
| LVDs, mean±SD (mm) | 65±8.0 | 66±6.3 | 0.43 |
| LA, mean±SD (mm) | 52±6.9 | 55±9.3 | 0.12 |
| EDVI, mean±SD (mL/m2) | 131±41 | 127±37 | 0.60 |
| ESVI, mean±SD (mL/m2) | 97±36 | 96±35 | 0.88 |
| RVDd, mean±SD (mm) | 39±6.4 | 40±6.5 | 0.41 |
| RVDs, mean±SD (mm) | 33±6.2 | 34±6.2 | 0.27 |
| Systolic pulmonary artery (mm Hg) | 54±17 | 55±14 | 0.73 |
| TAPSE, mean±SD (mm) | 15±4.8 | 14±4.5 | 0.40 |
| RVESP, mean±SD (mm Hg) | 52±17 | 56±14 | 0.21 |
CRT, cardiac resynchronisation therapy; EDVI, end-diastolic volume index; ESVI, end-systolic volume index; ICD, implanted cardioverter defibrillator; LA, left atrium; LEVF, left ventricular ejection fraction; LVDd, left ventricular diastolic diameter; LVDs, left ventricular systolic diameter; MR, mitral valve regurgitation; NYHA, New York Heart Association; PAD, peripheral artery disease; RVDd, right ventricular diastolic diameter; RVDs, right ventricular systolic diameter; RVESP, right ventricular end-systolic pressure; TAPSE, tricuspid annual plane systolic excursion; TR, tricuspid regurgitation.